Irish Specialty Pharmaceutical Producer Invest $2 Million To Establish US Headquarters in Hazelwood, Missouri
07/02/2013
The firm’s spinoff from former parent company, Covidien, makes it one of the largest public companies in St. Louis. The company is incorporated in Ireland and began officially trading on the New York Stock Exchange. Mallinckrodt's Hazelwood headquarters also serves as its U.S. headquarters. Mallinckrodt currently employs approximately 2,500 workers in the St. Louis area, and has more than 5,500 employees globally.
"As an active member of the St. Louis community for more than 145 years, we will continue to deliver the quality, integrity and service that the Mallinckrodt name is known for, and to help drive economic growth here in Missouri," said Mark Trudeau, President and CEO of Mallinckrodt. "We thank Gov. Nixon and the state of Missouri for their support, and appreciate Acting Department of Economic Development Director Mike Downing's participation in the celebration of our historic launch."
"Missouri companies are leading the way in the health science industry," Gov. Jay Nixon said. "Mallinckrodt's decision to establish the Hazelwood facility as its U.S. headquarters solidifies Missouri's place at the top of the health science industry and keeps our economy moving forward. It's certainly cause for celebration."
Project Announcements
AMI Metals Expands Spokane, Washington, Production Operations
06/20/2025
Newly Weds Foods Plans Dyersburg, Tennessee, Production Operations
06/20/2025
Yaskawa American Expands Franklin, Wisconsin, Headquarters Operations
06/19/2025
Cayuga Milk Ingredients Expands Cayuga County, New York, Production Operations
06/19/2025
Gap Upgrades Gallatin, Tennessee, Logistics Operations
06/19/2025
Swiss-Based Galderma Plans Miami, Florida, Headquarters Operations
06/19/2025
Most Read
-
20th Annual Area Development Gold and Silver Shovel Awards
Q2 2025
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Rethinking Life Sciences Site Selection in a Resilient and Dynamic Market
Q2 2025
-
The New Math Behind Mexico and U.S. Manufacturing Decisions
Q2 2025